EE200300489A - UK114-valgu või selle fragmentide kasutamine endotoksilise šoki raviks ja vältimiseks - Google Patents

UK114-valgu või selle fragmentide kasutamine endotoksilise šoki raviks ja vältimiseks

Info

Publication number
EE200300489A
EE200300489A EEP200300489A EEP200300489A EE200300489A EE 200300489 A EE200300489 A EE 200300489A EE P200300489 A EEP200300489 A EE P200300489A EE P200300489 A EEP200300489 A EE P200300489A EE 200300489 A EE200300489 A EE 200300489A
Authority
EE
Estonia
Prior art keywords
fragments
protein
prevention
treatment
endotoxic shock
Prior art date
Application number
EEP200300489A
Other languages
English (en)
Inventor
Bartorelli Alberto
Nicoletti Pierferdinando
Panerai Alberto
Original Assignee
Zetesis S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis S.P.A. filed Critical Zetesis S.P.A.
Publication of EE200300489A publication Critical patent/EE200300489A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
EEP200300489A 2001-04-10 2002-04-09 UK114-valgu või selle fragmentide kasutamine endotoksilise šoki raviks ja vältimiseks EE200300489A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI000762A ITMI20010762A1 (it) 2001-04-10 2001-04-10 Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
PCT/EP2002/003933 WO2002083161A1 (en) 2001-04-10 2002-04-09 Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock

Publications (1)

Publication Number Publication Date
EE200300489A true EE200300489A (et) 2003-12-15

Family

ID=11447468

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300489A EE200300489A (et) 2001-04-10 2002-04-09 UK114-valgu või selle fragmentide kasutamine endotoksilise šoki raviks ja vältimiseks

Country Status (22)

Country Link
US (1) US20040180835A1 (et)
EP (1) EP1377308A1 (et)
JP (1) JP2004526762A (et)
KR (1) KR20040000423A (et)
CN (1) CN1501807A (et)
BG (1) BG108246A (et)
BR (1) BR0208793A (et)
CA (1) CA2443726A1 (et)
CZ (1) CZ20032744A3 (et)
EE (1) EE200300489A (et)
HR (1) HRP20030815A2 (et)
HU (1) HUP0303798A3 (et)
IL (1) IL158333A0 (et)
IT (1) ITMI20010762A1 (et)
MX (1) MXPA03009228A (et)
NO (1) NO20034723L (et)
PL (1) PL367764A1 (et)
RU (1) RU2003130226A (et)
SK (1) SK12582003A3 (et)
WO (1) WO2002083161A1 (et)
YU (1) YU80003A (et)
ZA (1) ZA200307901B (et)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IL129024A0 (en) * 1996-09-18 2000-02-17 Zetesis Spa Use of proteins as agent against autoimmune diseases
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche

Also Published As

Publication number Publication date
US20040180835A1 (en) 2004-09-16
CN1501807A (zh) 2004-06-02
JP2004526762A (ja) 2004-09-02
HUP0303798A3 (en) 2005-12-28
WO2002083161A1 (en) 2002-10-24
PL367764A1 (en) 2005-03-07
BG108246A (bg) 2005-04-30
NO20034723D0 (no) 2003-10-22
IL158333A0 (en) 2004-05-12
BR0208793A (pt) 2004-03-09
KR20040000423A (ko) 2004-01-03
ITMI20010762A1 (it) 2002-10-10
ZA200307901B (en) 2004-10-11
HUP0303798A2 (hu) 2004-03-01
HRP20030815A2 (en) 2005-08-31
RU2003130226A (ru) 2005-02-10
SK12582003A3 (sk) 2004-03-02
CZ20032744A3 (en) 2004-05-12
MXPA03009228A (es) 2004-03-16
CA2443726A1 (en) 2002-10-24
ITMI20010762A0 (it) 2001-04-10
EP1377308A1 (en) 2004-01-07
NO20034723L (no) 2003-10-22
YU80003A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
EP1517724A4 (en) ANTI-ANGIOGENIC PROTEINS, THEIR FRAGMENTS AND METHODS OF USE
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
EA200500098A1 (ru) Лекарственное средство и способ лечения патологического синдрома
FI20010523A0 (fi) Soolien, geelien ja niiden seosten käsittely
NO20034437L (no) Gangliosid-assosierte rekombinante antistoffer og anvendelse derav ved diagnostikk og behandling av tumorer
NO20054913D0 (no) Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
NO20052699D0 (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
NO20033443D0 (no) Anvendelse av CD-2-bindende midler ved behandling eller forebygging av hudlidelser
EE200300474A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
NO20041214L (no) Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
DK1462455T3 (da) Ser-Ser-Ser-Arg-peptid samt medicinske anvendelser deraf
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
EE200300328A (et) IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks
PT1274700E (pt) Di-hidrobenzopiranos di-hidrobenzotiopiranos e tetra-hidroquinolinas para o tratamento de afeccoes mediadas por cox-2
PT1381620E (pt) Dissacaridos hipersulfatados e metodos de utilizacao dos mesmos para o tratamento de inflamacoes
DE60236649D1 (de) Methode zur entfernung von allergenen
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
EE200300489A (et) UK114-valgu või selle fragmentide kasutamine endotoksilise šoki raviks ja vältimiseks
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse
EP1432448A4 (en) NOVEL HKID-1-ASSOCIATED PROTEIN FAMILY MOLECULES AND USES THEREOF
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
PT1214409E (pt) Acidos nucleicos e polipeptidos do factor de crescimento de fibroblastos-19 (fgf-19) e metodos de utilizacao para o tratamento de obesidade